This country approves Ozempic to reduce risk of kidney disease in diabetes patients
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing kidney failure risk, disease progression, and death due to ...
CNN on MSN13 天
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...
kcra.com13 天
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
"Ozempic and other semaglutide injections such ... It also reduced the risk of kidney failure and cut the risk of death from heart disease by about 5% in adults with both type 2 diabetes and ...